Data for Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer (part I) (Study ST000388)
(Analysis AN000624)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this studyMetabolite | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 | F16 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glutamine | 1.1079 | 1.0074 | 1.2575 | 0.9185 | 1.6164 | 1.8942 | 1.4432 | 0.9619 | 0.5457 | 0.9459 | 0.7616 | 1.0636 | 0.3788 | 1.1668 | 0.7120 | 0.9329 |
Methionine | 1.1944 | 1.0275 | 1.3884 | 0.8975 | 0.9810 | 1.7347 | 1.2244 | 0.8462 | 0.7466 | 1.0867 | 0.8691 | 0.9707 | 0.3713 | 1.0572 | 0.6914 | 0.9301 |
PC 38:7 | 0.9208 | 1.0919 | 1.0389 | 1.0482 | 1.0409 | 0.9625 | 0.8788 | 1.0294 | 1.0346 | 0.9503 | 1.0563 | 1.0366 | 0.8875 | 0.8611 | 1.0689 | 1.0322 |
PE (38:4) [M+H]+ | 0.7346 | 1.1995 | 0.9004 | 0.9369 | 0.6253 | 0.8171 | 0.8972 | 0.9076 | 1.2923 | 0.8939 | 0.9955 | 1.1390 | 2.0060 | 1.0330 | 1.1262 | 0.9033 |
Phenylalanine | 1.2436 | 1.0651 | 1.4085 | 0.9548 | 0.8484 | 1.0873 | 1.3261 | 0.9781 | 0.5874 | 1.0933 | 0.8816 | 0.9286 | 0.6404 | 0.9372 | 0.7184 | 1.0535 |
Pyroglutamic acid | 1.1996 | 1.0077 | 1.2228 | 0.9110 | 1.6224 | 2.0084 | 1.4172 | 0.9640 | 0.5196 | 0.9338 | 0.7980 | 1.0758 | 0.3450 | 1.1809 | 0.6800 | 0.9273 |
Tryptophan | 1.0570 | 1.0980 | 1.4314 | 1.0027 | 0.7481 | 1.5589 | 1.0857 | 1.1134 | 0.8121 | 0.9613 | 1.1324 | 0.8257 | 0.5145 | 0.9116 | 0.6230 | 1.1029 |
Factors:
F1 | Smoking Status:Current | Gender:Female | Emphysema/COPD:No | Group:Benign |
F2 | Smoking Status:Current | Gender:Female | Emphysema/COPD:No | Group:Cancer |
F3 | Smoking Status:Current | Gender:Female | Emphysema/COPD:Yes | Group:Benign |
F4 | Smoking Status:Current | Gender:Female | Emphysema/COPD:Yes | Group:Cancer |
F5 | Smoking Status:Current | Gender:Male | Emphysema/COPD:No | Group:Benign |
F6 | Smoking Status:Current | Gender:Male | Emphysema/COPD:No | Group:Cancer |
F7 | Smoking Status:Current | Gender:Male | Emphysema/COPD:Yes | Group:Benign |
F8 | Smoking Status:Current | Gender:Male | Emphysema/COPD:Yes | Group:Cancer |
F9 | Smoking Status:Former | Gender:Female | Emphysema/COPD:No | Group:Benign |
F10 | Smoking Status:Former | Gender:Female | Emphysema/COPD:No | Group:Cancer |
F11 | Smoking Status:Former | Gender:Female | Emphysema/COPD:Yes | Group:Benign |
F12 | Smoking Status:Former | Gender:Female | Emphysema/COPD:Yes | Group:Cancer |
F13 | Smoking Status:Former | Gender:Male | Emphysema/COPD:No | Group:Benign |
F14 | Smoking Status:Former | Gender:Male | Emphysema/COPD:No | Group:Cancer |
F15 | Smoking Status:Former | Gender:Male | Emphysema/COPD:Yes | Group:Benign |
F16 | Smoking Status:Former | Gender:Male | Emphysema/COPD:Yes | Group:Cancer |